MoneyWorks4Me

Kopran informs about results & closure of trading window

23 Apr 2016 Evaluate

Kopran has informed that a Meeting of the Board of Directors of the Company will be held on May 30, 2016, to consider approve and take on record the audited financial results of the Company for the Fourth Quarter and Year ended March 31, 2016, the audited Consolidated Financial Results of the Company and its subsidiaries for the Fourth Quarter and Year ended March 31, 2016. Further, the Trading Window in respect of Company’s Securities shall remain closed for all the Directors /Officers/ Designated Employees of the Company from the opening of the trading hours on May 26, 2016 till the close of the trading hours on June 01, 2016 as per the Code of Conduct for Prohibition of Insider Trading.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1835.50
Dr. Reddys Labs. 1171.10
Cipla 1371.45
Lupin 2144.70
Zydus Lifesciences 1153.00
View more..